NeoGenomics shareholders approve 5M share increase to equity compensation plan

Filed May 22, 2026 · Period ending May 21, 2026 · ~1 min read

Key Changes

• medium

  Stockholders approved adding 5 million shares to the 2023 Equity Incentive Plan, expanding the pool available for employee stock grants and options. This dilutes existing shareholders but allows the company to continue equity-based compensation.

  Item 5.07 verify on EDGAR →
• low

  All nine director nominees were re-elected to the board at the May 21 annual meeting, including Lynn Tetrault, Dr. Marjorie Green, Dr. Neil Gunn, and six others. No board composition changes.

  Item 5.07 verify on EDGAR →
• low

  Executive compensation received advisory approval with 83% of votes cast in favor, though 17% voted against the pay packages for Named Executive Officers.

  Item 5.07 verify on EDGAR →